Fuller & Thaler Asset Management’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-271,384	Closed	-$1.47M	–	478
2018 Q3	$1.47M	Hold	271,384	–	–	0.02%	321
2018 Q2	$963K	Hold	271,384	–	–	0.01%	332
2018 Q1	$556K	Sell	271,384 -20,300	-7%	-$52.7K	0.01%	348
2017 Q4	$770K	Sell	291,684 -93,655	-24%	-$328K	0.01%	330
2017 Q3	$2.02M	Sell	385,339 -1,900	-0.5%	-$8.17K	0.02%	244
2017 Q2	$1.38M	Sell	387,239 -1,500	-0.4%	-$6.05K	0.02%	260
2017 Q1	$2.01M	Hold	388,739	–	–	0.03%	213
2016 Q4	$1.48M	Hold	388,739	–	–	0.02%	226
2016 Q3	$3.48M	Sell	388,739 -11,900	-3%	-$99.5K	0.06%	162
2016 Q2	$2.82M	Hold	400,639	–	–	0.05%	167
2016 Q1	$3.4M	Sell	400,639 -127,800	-24%	-$1.26M	0.07%	148
2015 Q4	$6.94M	Buy	528,439 +25,000	+5%	+$224K	0.15%	114
2015 Q3	$1.84M	Buy	503,439 +400	+0.1%	+$1.96K	0.05%	204
2015 Q2	$2.9M	Buy	503,039 +10,500	+2%	+$60.8K	0.08%	174
2015 Q1	$2.88M	Sell	492,539 -1,600	-0.3%	-$11K	0.09%	182
2014 Q4	$3.87M	Buy	494,139 +7,400	+2%	+$47.4K	0.14%	156
2014 Q3	$2.39M	Sell	486,739 -100	-0%	-$523	0.1%	183
2014 Q2	$3.01M	Sell	486,839 -66,861	-12%	-$335K	0.13%	175
2014 Q1	$2.96M	Sell	553,700 -65,000	-11%	-$411K	0.14%	178
2013 Q4	$3.24M	Sell	618,700 -15,900	-3%	-$73K	0.18%	170
2013 Q3	$3.5M	Sell	634,600 -9,500	-1%	-$33K	0.21%	162
2013 Q2	$1.63M	Buy	+644,100	New	+$1.6M	0.11%	216